Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 8 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2026 Filed Mar 3, 2026 12:18 UTC |
DeFrancesco LisaSVP, IR and Corp Comm
|
Tax withholdingCommon Stock | 74,572 | $1.47 | $109,620.84 |
DisclosureSEC source: 0001062822-26-000037 · form4.xml · nonDerivative · entry 3 DeFrancesco Lisa · CIK 0001846325 · SVP, IR and Corp Comm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,869 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:18 UTC |
DeFrancesco LisaSVP, IR and Corp Comm
|
Exercise / conversionCommon Stock | 128,190 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000037 · form4.xml · nonDerivative · entry 2 DeFrancesco Lisa · CIK 0001846325 · SVP, IR and Corp Comm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:18 UTC |
DeFrancesco LisaSVP, IR and Corp Comm
|
Exercise / conversionCommon Stock | 24,674 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000037 · form4.xml · nonDerivative · entry 1 DeFrancesco Lisa · CIK 0001846325 · SVP, IR and Corp Comm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,251 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:18 UTC |
Gopinathan SumaSVP, Discovery
|
Exercise / conversionRestricted Stock Units · Derivative | 65,640 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000038 · form4.xml · derivative · entry 7 Gopinathan Suma · CIK 0002071581 · SVP, Discovery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,280 Underlying: Common Stock · 65,640 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:18 UTC |
Gopinathan SumaSVP, Discovery
|
Exercise / conversionRestricted Stock Units · Derivative | 20,310 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000038 · form4.xml · derivative · entry 6 Gopinathan Suma · CIK 0002071581 · SVP, Discovery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,310 Underlying: Common Stock · 20,310 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:18 UTC |
Gopinathan SumaSVP, Discovery
|
Exercise / conversionRestricted Stock Units · Derivative | 14,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000038 · form4.xml · derivative · entry 5 Gopinathan Suma · CIK 0002071581 · SVP, Discovery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:18 UTC |
Gopinathan SumaSVP, Discovery
|
Tax withholdingCommon Stock | 24,338 | $1.47 | $35,776.86 |
DisclosureSEC source: 0001062822-26-000038 · form4.xml · nonDerivative · entry 4 Gopinathan Suma · CIK 0002071581 · SVP, Discovery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,132 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:18 UTC |
Gopinathan SumaSVP, Discovery
|
Exercise / conversionCommon Stock | 65,640 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000038 · form4.xml · nonDerivative · entry 3 Gopinathan Suma · CIK 0002071581 · SVP, Discovery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:18 UTC |
Gopinathan SumaSVP, Discovery
|
Exercise / conversionCommon Stock | 20,310 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000038 · form4.xml · nonDerivative · entry 2 Gopinathan Suma · CIK 0002071581 · SVP, Discovery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:18 UTC |
Gopinathan SumaSVP, Discovery
|
Exercise / conversionCommon Stock | 14,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000038 · form4.xml · nonDerivative · entry 1 Gopinathan Suma · CIK 0002071581 · SVP, Discovery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:17 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionRestricted Stock Units · Derivative | 170,163 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000036 · form4.xml · derivative · entry 7 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,327 Underlying: Common Stock · 170,163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:17 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionRestricted Stock Units · Derivative | 33,457 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000036 · form4.xml · derivative · entry 6 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,457 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:17 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionRestricted Stock Units · Derivative | 69,386 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000036 · form4.xml · derivative · entry 5 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,387 Underlying: Common Stock · 69,386 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:17 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Tax withholdingCommon Stock | 105,019 | $1.47 | $154,377.93 |
DisclosureSEC source: 0001062822-26-000036 · form4.xml · nonDerivative · entry 4 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 428,802 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:17 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionCommon Stock | 170,163 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000036 · form4.xml · nonDerivative · entry 3 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 533,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:17 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionCommon Stock | 69,386 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000036 · form4.xml · nonDerivative · entry 2 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:17 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionCommon Stock | 33,457 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000036 · form4.xml · nonDerivative · entry 1 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:16 UTC |
Coiante Scott MSVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 160,237 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000035 · form4.xml · derivative · entry 3 Coiante Scott M · CIK 0001608536 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,473 Underlying: Common Stock · 160,237 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:16 UTC |
Coiante Scott MSVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 54,881 | $1.47 | $80,675.07 |
DisclosureSEC source: 0001062822-26-000035 · form4.xml · nonDerivative · entry 2 Coiante Scott M · CIK 0001608536 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,356 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:16 UTC |
Coiante Scott MSVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 160,237 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000035 · form4.xml · nonDerivative · entry 1 Coiante Scott M · CIK 0001608536 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:15 UTC |
Exton MichaelDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 503,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000034 · form4.xml · derivative · entry 3 Exton Michael · CIK 0002029249 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,006,527 Underlying: Common Stock · 503,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:15 UTC |
Exton MichaelDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 204,831 | $1.47 | $301,101.57 |
DisclosureSEC source: 0001062822-26-000034 · form4.xml · nonDerivative · entry 2 Exton Michael · CIK 0002029249 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 298,432 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 12:15 UTC |
Exton MichaelDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 503,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062822-26-000034 · form4.xml · nonDerivative · entry 1 Exton Michael · CIK 0002029249 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 503,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 13:33 UTC |
DEBBANE RAYMONDDirector
|
PurchaseCommon Stock | 2,000 | $1.49 | $2,980.00 |
DisclosureSEC source: 0001062822-26-000033 · form4.xml · nonDerivative · entry 1 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,906,186 Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 12:00 UTC |
DEBBANE RAYMONDDirector
|
PurchaseCommon Stock | 100,000 | $1.47 | $147,000.00 |
DisclosureSEC source: 0001062822-26-000032 · form4.xml · nonDerivative · entry 1 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,904,186 Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 12:49 UTC |
DEBBANE RAYMONDDirector
|
PurchaseCommon Stock | 100,000 | $1.48 | $147,790.00 |
DisclosureSEC source: 0001062822-26-000031 · form4.xml · nonDerivative · entry 2 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,804,186 F2 · price: Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.49 per share. The reporting person hereby undertakes to provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 12:49 UTC |
DEBBANE RAYMONDDirector
|
PurchaseCommon Stock | 50,000 | $1.44 | $71,965.00 |
DisclosureSEC source: 0001062822-26-000031 · form4.xml · nonDerivative · entry 1 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,704,186 F1 · price: Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.425 to $1.455 per share. The reporting person hereby undertakes to provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Read SEC document |
| February 18, 2026 Filed Feb 18, 2026 21:30 UTC |
DEBBANE RAYMONDDirector
|
PurchaseCommon Stock | 133,688 | $1.32 | $176,468.16 |
DisclosureSEC source: 0001062822-26-000029 · form4.xml · nonDerivative · entry 3 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,654,186 F3 · price: Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.315 to $1.32 per share. The reporting person hereby undertakes to provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:30 UTC |
DEBBANE RAYMONDDirector
|
PurchaseCommon Stock | 76,857 | $1.31 | $100,544.33 |
DisclosureSEC source: 0001062822-26-000029 · form4.xml · nonDerivative · entry 2 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,520,498 F2 · price: Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.295 to $1.31 per share. The reporting person hereby undertakes to provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:50 UTC |
Artal Participations S.a r.l.Director · 10% owner
Artal International S.C.A.Director · 10% owner
Artal International Management S.A.Director · 10% owner
Artal Group S.A.Director · 10% owner
Westend S.A.Director · 10% owner
Stichting Administratiekantoor WestendDirector · 10% owner
Wittouck AmauryDirector · 10% owner
|
GrantSeries B Convertible Preferred Stock | 41,289.58 | $65.00 | $2,683,822.70 |
DisclosureSEC source: 0001193125-26-059599 · ownership.xml · nonDerivative · entry 1 Artal Participations S.a r.l. · CIK 0002048403 · Director · 10% owner Artal International S.C.A. · CIK 0001218180 · Director · 10% owner Artal International Management S.A. · CIK 0001522131 · Director · 10% owner Artal Group S.A. · CIK 0001053906 · Director · 10% owner Westend S.A. · CIK 0001283968 · Director · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · Director · 10% owner Wittouck Amaury · CIK 0001841311 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 408,434.7 F1 · kind: Pursuant to that certain preferred stock purchase agreement (the "Purchase Agreement") with the Issuer, dated as of January 29, 2026, in connection with the underwriter's partial exercise of their option to purchase additional shares of Issuer common stock par value $0.001 per share (the "Common Stock") in an underwritten public offering, Artal Participations S.a r.l. purchased an additional 41,289.58 shares of Issuer Series B Convertible Preferred Stock, par value $0.01 per share (the "Preferred Stock") at a price of $65.00 per share. Each share of Preferred Stock will automatically convert into 50 shares of Common Stock upon receipt of shareholder approval and the satisfaction of certain other conditions; however, absent the satisfaction of such conditions, the shares are not convertible. F2 · ownership.nature: These securities are directly held by Artal Participations S.a r.l. F3 · ownership.nature: The sole shareholder of Artal Participations S.a r.l. is Artal International S.C.A. The managing partner of Artal International S.C.A. is Artal International Management S.A. The sole stockholder of Artal International Management S.A. is Artal Group S.A. The parent company of Artal Group S.A. is Westend S.A. The majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend (the "Stichting"). Mr. Amaury Wittouck is the sole member of the board of the Stichting. F4 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:30 UTC |
DEBBANE RAYMONDDirector
|
PurchaseCommon Stock | 57,952 | $1.31 | $75,876.55 |
DisclosureSEC source: 0001062822-26-000029 · form4.xml · nonDerivative · entry 1 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,443,641 F1 · price: Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.31 per share. The reporting person hereby undertakes to provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:10 UTC |
McDermott WendySVP, Human Resources
|
GrantStock Option (Right to Buy) · Derivative | 375,300 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001062822-26-000026 · form4.xml · derivative · entry 2 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,300 Underlying: Common Stock · 375,300 shares Expires 2036-02-12 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:10 UTC |
McDermott WendySVP, Human Resources
|
GrantRestricted Stock Units · Derivative | 250,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000026 · form4.xml · derivative · entry 1 McDermott Wendy · CIK 0001902760 · SVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,200 Underlying: Common Stock · 250,200 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:10 UTC |
Martens Rachel YapSVP, Partnerships & Corp Strat
|
GrantStock Option (Right to Buy) · Derivative | 290,620 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001062822-26-000025 · form4.xml · derivative · entry 2 Martens Rachel Yap · CIK 0002071589 · SVP, Partnerships & Corp Strat 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,620 Underlying: Common Stock · 290,620 shares Expires 2036-02-12 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:10 UTC |
Martens Rachel YapSVP, Partnerships & Corp Strat
|
GrantRestricted Stock Units · Derivative | 193,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000025 · form4.xml · derivative · entry 1 Martens Rachel Yap · CIK 0002071589 · SVP, Partnerships & Corp Strat 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,740 Underlying: Common Stock · 193,740 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:09 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 519,920 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001062822-26-000024 · form4.xml · derivative · entry 2 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 519,920 Underlying: Common Stock · 519,920 shares Expires 2036-02-12 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:09 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
GrantRestricted Stock Units · Derivative | 346,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000024 · form4.xml · derivative · entry 1 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,610 Underlying: Common Stock · 346,610 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:08 UTC |
Gopinathan SumaSVP, Discovery
|
GrantStock Option (Right to Buy) · Derivative | 357,680 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001062822-26-000023 · form4.xml · derivative · entry 2 Gopinathan Suma · CIK 0002071581 · SVP, Discovery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 357,680 Underlying: Common Stock · 357,680 shares Expires 2036-02-12 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:08 UTC |
Gopinathan SumaSVP, Discovery
|
GrantRestricted Stock Units · Derivative | 238,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000023 · form4.xml · derivative · entry 1 Gopinathan Suma · CIK 0002071581 · SVP, Discovery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,450 Underlying: Common Stock · 238,450 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:07 UTC |
DeFrancesco LisaSVP, IR and Corp Comm
|
GrantStock Option (Right to Buy) · Derivative | 386,300 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001062822-26-000022 · form4.xml · derivative · entry 2 DeFrancesco Lisa · CIK 0001846325 · SVP, IR and Corp Comm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,300 Underlying: Common Stock · 386,300 shares Expires 2036-02-12 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:07 UTC |
DeFrancesco LisaSVP, IR and Corp Comm
|
GrantRestricted Stock Units · Derivative | 257,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000022 · form4.xml · derivative · entry 1 DeFrancesco Lisa · CIK 0001846325 · SVP, IR and Corp Comm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,530 Underlying: Common Stock · 257,530 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:07 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
GrantStock Option (Right to Buy) · Derivative | 449,560 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001062822-26-000021 · form4.xml · derivative · entry 2 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 449,560 Underlying: Common Stock · 449,560 shares Expires 2036-02-12 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:07 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
GrantRestricted Stock Units · Derivative | 299,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000021 · form4.xml · derivative · entry 1 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,710 Underlying: Common Stock · 299,710 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:06 UTC |
Coiante Scott MSVP, Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 409,020 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001062822-26-000020 · form4.xml · derivative · entry 2 Coiante Scott M · CIK 0001608536 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,020 Underlying: Common Stock · 409,020 shares Expires 2036-02-12 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:06 UTC |
Coiante Scott MSVP, Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 272,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000020 · form4.xml · derivative · entry 1 Coiante Scott M · CIK 0001608536 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,680 Underlying: Common Stock · 272,680 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:05 UTC |
Exton MichaelDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 1,293,670 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001062822-26-000019 · form4.xml · derivative · entry 2 Exton Michael · CIK 0002029249 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,293,670 Underlying: Common Stock · 1,293,670 shares Expires 2036-02-12 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:05 UTC |
Exton MichaelDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 862,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000019 · form4.xml · derivative · entry 1 Exton Michael · CIK 0002029249 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 862,440 Underlying: Common Stock · 862,440 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:25 UTC |
Invus Global Management, LLCDirector · 10% owner
Siren, L.L.C.Director · 10% owner
DEBBANE RAYMONDDirector
Artal Participations S.a r.l.Director · 10% owner
Artal International S.C.A.Director · 10% owner
Artal International Management S.A.Director · 10% owner
Artal Group S.A.Director · 10% owner
Westend S.A.Director · 10% owner
Stichting Administratiekantoor WestendDirector · 10% owner
|
GrantSeries B Convertible Preferred Stock | 367,145.12 | $65.00 | $23,864,432.80 |
DisclosureSEC source: 0001193125-26-037644 · ownership.xml · nonDerivative · entry 4 Invus Global Management, LLC · CIK 0002005369 · Director · 10% owner Siren, L.L.C. · CIK 0002005245 · Director · 10% owner DEBBANE RAYMOND · CIK 0001053890 · Director Artal Participations S.a r.l. · CIK 0002048403 · Director · 10% owner Artal International S.C.A. · CIK 0001218180 · Director · 10% owner Artal International Management S.A. · CIK 0001522131 · Director · 10% owner Artal Group S.A. · CIK 0001053906 · Director · 10% owner Westend S.A. · CIK 0001283968 · Director · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 367,145.12 F3 · kind: On January 29, 2026, Artal Participations S.a r.l. entered into a preferred stock purchase agreement (the "Preferred Purchase Agreement") with the Issuer pursuant to which Artal Participations S.a r.l. agreed to purchase 367,145.12 shares of Series B Convertible Preferred Stock, par value $0.01 per share (the "Preferred Stock") of the Issuer at a price of $65.00 per share. The Preferred Purchase Agreement also provides Artal Participations S.a r.l. the right to purchase from the Issuer, up to an additional 94,854.88 shares of Preferred Stock at a price per share of $65.00. Each share of Preferred Stock will automatically convert into 50 shares of the Issuer's Common Stock upon receipt of shareholder approval and the satisfaction of certain other conditions; however, absent the satisfaction of such conditions, the shares are not convertible. The purchase closed on February 2, 2026. F4 · ownership.nature: These securities are directly held by Artal Participations S.a r.l. F9 · ownership.nature: The sole shareholder of Artal Participations S.a r.l. is Artal International S.C.A. The managing partner of Artal International S.C.A. is Artal International Management S.A. The sole stockholder of Artal International Management S.A. is Artal Group S.A. The parent company of Artal Group S.A. is Westend S.A. The majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend (the "Stichting"). Mr. Amaury Wittouck is the sole member of the board of the Stichting. F15 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:25 UTC |
Invus Global Management, LLCDirector · 10% owner
Siren, L.L.C.Director · 10% owner
DEBBANE RAYMONDDirector
Artal Participations S.a r.l.Director · 10% owner
Artal International S.C.A.Director · 10% owner
Artal International Management S.A.Director · 10% owner
Artal Group S.A.Director · 10% owner
Westend S.A.Director · 10% owner
Stichting Administratiekantoor WestendDirector · 10% owner
|
PurchaseCommon Stock | 1,538,462 | $1.30 | $2,000,000.60 |
DisclosureSEC source: 0001193125-26-037644 · ownership.xml · nonDerivative · entry 3 Invus Global Management, LLC · CIK 0002005369 · Director · 10% owner Siren, L.L.C. · CIK 0002005245 · Director · 10% owner DEBBANE RAYMOND · CIK 0001053890 · Director Artal Participations S.a r.l. · CIK 0002048403 · Director · 10% owner Artal International S.C.A. · CIK 0001218180 · Director · 10% owner Artal International Management S.A. · CIK 0001522131 · Director · 10% owner Artal Group S.A. · CIK 0001053906 · Director · 10% owner Westend S.A. · CIK 0001283968 · Director · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,538,462 F2 · kind: On February 2, 2026, Avicenna Life Sci Master Fund LP purchased 1,538,462 shares of Common Stock as part of the Issuer's underwritten public offering. F6 · ownership.nature: These securities are directly held by Avicenna Life Sci Master Fund LP F11 · ownership.nature: The general partner of Avicenna Life Sci Master Fund LP is Avicenna Life Sci Master GP LLC. The managing member of Avicenna Life Sci Master GP LLC is Ulys, L.L.C. The managing member of Ulys, L.L.C. is Mr. Raymond Debbane. F15 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:25 UTC |
Invus Global Management, LLCDirector · 10% owner
Siren, L.L.C.Director · 10% owner
DEBBANE RAYMONDDirector
Artal Participations S.a r.l.Director · 10% owner
Artal International S.C.A.Director · 10% owner
Artal International Management S.A.Director · 10% owner
Artal Group S.A.Director · 10% owner
Westend S.A.Director · 10% owner
Stichting Administratiekantoor WestendDirector · 10% owner
|
GrantCommon Stock | 3,846,154 | $1.30 | $5,000,000.20 |
DisclosureSEC source: 0001193125-26-037644 · ownership.xml · nonDerivative · entry 2 Invus Global Management, LLC · CIK 0002005369 · Director · 10% owner Siren, L.L.C. · CIK 0002005245 · Director · 10% owner DEBBANE RAYMOND · CIK 0001053890 · Director Artal Participations S.a r.l. · CIK 0002048403 · Director · 10% owner Artal International S.C.A. · CIK 0001218180 · Director · 10% owner Artal International Management S.A. · CIK 0001522131 · Director · 10% owner Artal Group S.A. · CIK 0001053906 · Director · 10% owner Westend S.A. · CIK 0001283968 · Director · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 7,362,368 F1 · kind: On January 29, 2026, Artal Participations S.a r.l. entered into a purchase agreement with the Issuer pursuant to which Artal Participations S.a r.l. agreed to purchase 22,400,000 shares of common stock par value $0.001 per share (the "Common Stock") of the Issuer at a price of $1.30 per share (the "Purchase Price"). On January 30, 2026, Artal Participations S.a r.l. assigned its right to purchase from the Issuer 3,846,154 shares of Issuer Common Stock to Invus Public Equities, L.P., and Invus Public Equities, L.P. agreed to purchase directly from the Issuer 3,846,154 shares of Issuer Common Stock at the Purchase Price. The purchase closed on February 2, 2026. F5 · ownership.nature: These securities are directly held by Invus Public Equities, L.P. F10 · ownership.nature: The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. The managing member of Invus Public Equities Advisors, LLC is Invus Global Management, LLC. The managing member of Invus Global Management, LLC is Siren, L.L.C. The managing member of Siren, L.L.C. is Mr. Raymond Debbane. F15 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.